WHO approval for AstraZeneca vaccine should come soon: Serum CEO

Serum CEO Poonawalla said his company would start stockpiling millions of doses of the Novavax coronavirus vaccine candidate from around April

The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and low income countries, its chief executive said.

“The emergency use licensure from the WHO (World Health Organization) should be available and coming through in the next week or two, hopefully, because we have submitted everything,” Adar Poonawalla told the Reuters Next conference on Thursday.

Poonawalla also said his company, the world’s biggest vaccine maker, would start stockpiling millions of doses of the Novavax coronavirus vaccine candidate from around April.